Literature DB >> 35862706

Controlling Herpes Simplex Virus-Induced Immunoinflammatory Lesions Using Metabolic Therapy: a Comparison of 2-Deoxy-d-Glucose with Metformin.

Engin Berber1, Barry T Rouse1.   

Abstract

Herpes simplex virus (HSV) infection of the eye can result in a blinding immunoinflammatory lesion in the cornea called herpetic stromal keratitis (HSK). This lesion is orchestrated by T cells and can be reduced in magnitude by anti-inflammatory drugs and procedures that change the balance of cellular participants in lesions. This report evaluates the effect of drugs that cause metabolic reprogramming on lesion expression using two drugs that affect glucose metabolism: 2-deoxy-d-glucose (2DG) and metformin. Both drugs could limit HSK severity, but 2DG therapy could result in herpes encephalitis if used when replicating virus was still present. The reason metformin was a safer therapy was its lack of marked inhibitory effects on inflammatory cells particularly interferon-γ (IFN-γ)-producing Th1 and CD8 T cells in the trigeminal ganglion (TG), in which HSV latency is established and sustained. Additionally, whereas 2DG in TG cultures with established latency accelerated the termination of latency, this did not occur in the presence of metformin, likely because the inflammatory cells remained functional. Our results support the value of metabolic reprogramming to control viral immunoinflammatory lesions, but the approach used should be chosen with caution. IMPORTANCE Herpes simplex virus (HSV) infection of the eye is an example where damaging lesions are in part the consequence of a host response to the infection. Moreover, it was shown that changing the representation of cellular participants in the inflammatory reaction can minimize lesion severity. This report explores the value of metabolic reprogramming using two drugs that affect glucose metabolism to achieve cellular rebalancing. It showed that two drugs, 2-deoxy-d-glucose (2DG) and metformin, effectively diminished ocular lesion expression, but only metformin avoided the complication of HSV spreading to the central nervous system (CNS) and causing herpetic encephalitis. The report provides some mechanistic explanations for the findings.

Entities:  

Keywords:  2-deoxy-d-glucose; 2DG; HSK; HSV-1; encephalitis; herpes simplex virus; herpetic stromal keratitis; metformin

Mesh:

Substances:

Year:  2022        PMID: 35862706      PMCID: PMC9327707          DOI: 10.1128/jvi.00688-22

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  41 in total

1.  Metformin and reduced risk of cancer in diabetic patients.

Authors:  Josie M M Evans; Louise A Donnelly; Alistair M Emslie-Smith; Dario R Alessi; Andrew D Morris
Journal:  BMJ       Date:  2005-04-22

Review 2.  Immunity causing blindness: five different paths to herpes stromal keratitis.

Authors:  J W Streilein; M R Dana; B R Ksander
Journal:  Immunol Today       Date:  1997-09

3.  Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase.

Authors:  Carolyn Algire; Lilian Amrein; Mahvash Zakikhani; Lawrence Panasci; Michael Pollak
Journal:  Endocr Relat Cancer       Date:  2010-06-01       Impact factor: 5.678

Review 4.  Targeting Metabolism as a Novel Therapeutic Approach to Autoimmunity, Inflammation, and Transplantation.

Authors:  Ian A Bettencourt; Jonathan D Powell
Journal:  J Immunol       Date:  2017-02-01       Impact factor: 5.422

Review 5.  Immune control of herpes simplex virus during latency.

Authors:  Kamal M Khanna; Andrew J Lepisto; Vilma Decman; Robert L Hendricks
Journal:  Curr Opin Immunol       Date:  2004-08       Impact factor: 7.486

6.  Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice.

Authors:  Yafei Sun; Tian Tian; Juan Gao; Xiaoqian Liu; Huiqing Hou; Runjing Cao; Bin Li; Moyuan Quan; Li Guo
Journal:  J Neuroimmunol       Date:  2016-01-18       Impact factor: 3.478

7.  Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer In Vitro and In Vivo.

Authors:  Shilpa Thakur; Brianna Daley; Kelli Gaskins; Vasyl V Vasko; Myriem Boufraqech; Dhaval Patel; Carole Sourbier; Jeff Reece; Sheue-Yann Cheng; Electron Kebebew; Sunita Agarwal; Joanna Klubo-Gwiezdzinska
Journal:  Clin Cancer Res       Date:  2018-04-24       Impact factor: 12.531

8.  Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase.

Authors:  Anila K Madiraju; Derek M Erion; Yasmeen Rahimi; Xian-Man Zhang; Demetrios T Braddock; Ronald A Albright; Brett J Prigaro; John L Wood; Sanjay Bhanot; Michael J MacDonald; Michael J Jurczak; Joao-Paulo Camporez; Hui-Young Lee; Gary W Cline; Varman T Samuel; Richard G Kibbey; Gerald I Shulman
Journal:  Nature       Date:  2014-05-21       Impact factor: 49.962

Review 9.  The Role of T Cells in Herpes Stromal Keratitis.

Authors:  Naveen K Rajasagi; Barry T Rouse
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

10.  Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Melanie J Davies; David A D'Alessio; Judith Fradkin; Walter N Kernan; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Apostolos Tsapas; Deborah J Wexler; John B Buse
Journal:  Diabetes Care       Date:  2018-10-04       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.